India
Joined April 2009
- Tweets5.4K
- Following196
- Followers1.4K
- Likes5.9K
Sheela Panicker retweeted
Check out today’s #cityexpress, where Anthony Pettis and Neeraj Goyat discuss what it will take to put Indian boxing on the global map ahead of their much-anticipated face-off
@MSKiranPrakash @Kalyan_TNIE @Reshmijourno
For more stories newindianexpress.com/cities/…
Sheela Panicker retweeted
May Diwali bring fresh energy, brighter beginnings and endless sparkle! ✨🪔
#HappyDiwali #enRightPR
A visually grand and emotionally engaging retelling of the #RamayanaMovie , blending mythology, devotion, and spectacular storytelling. Absolutely a great watch #RamayanaPart1 #Ramayana
Ramayana Movie Review: Ranbir, Yash Make This Epic Worth Watching
#RamayanaMovie #RamayanaReview #RanbirKapoor #Yash #BollywoodMovies #MovieReview
filmykeema.com/ramayana-movi… via @filmykeema
156
Sheela Panicker retweeted
According to World Bank's latest report, India's extreme poverty has fallen from 27.6% to just under 2.6%.
And for Indians living under Rs. 400 a day (lower middle income), it has come down from 57.7% of the population to 16.1%.
Remarkable achievement by India given the rupee depreciated and the inflationary pressure of a fast growing economy.
Sheela Panicker retweeted
Nucelion Therapeutics has partnered with Pandorum Technologies to develop investigational therapies for advanced keratopathy and wet age-related macular degeneration (AMD).
(@joecmathew reports)
#Biotech #Healthcare #NucelionTherapeutics
fortuneindia.com/business-ne…
Sheela Panicker retweeted
Bharat Biotech arm Nucelion to collaborate with Pandorum Tech on two PRIP-backed projects
thehindu.com/news/cities/Hyd…
Sheela Panicker retweeted
Bharat Biotech’s Nucelion Joins Pandorum for 2 New Investigational Eye Therapies
@BharatBiotech #NucelionTherapeutics #PandorumTechnologies #Hyderabad #Bengaluru #Science #Healthcare #Partnership
startupstars.in/funding-aler… via @Startupstars_IN
Sheela Panicker retweeted
Bharat Biotech Arm Backs New Path to Designer-Exosome Therapies for Eye Disease
@BharatBiotech #NucelionTherapeutics #PandorumTechnologies #Science #BiotechnologyNews
thenewsfacts.com/latest-news… via @thenewsfactsnow
Sheela Panicker retweeted
#MalariaVaccine 40% Cheaper, Protecting 1 Million More Children
A major boost in the fight against malaria!
An agreement between Bharat Biotech, Gavi and UNICEF will reduce the vaccine price to €5.50 per dose. Effective from 2027, the price cut is expected to save around $50 million over three years, helping expand protection for children against malaria.
Sheela Panicker retweeted
#Pharma major #BharatBiotechInternational (BBIL) will cut the price of its #malaria vaccine #Mosqivac by around 40% under an agreement with #Gavi, the #VaccineAlliance and #UNICEF
business-standard.com/s/2gA6… | @koul_sanket
Sheela Panicker retweeted
Hyderabad engineer Aarav Garg helps develop Persona’s screenless, voice-enabled AI wristband newsmeter.in/tech-startups/h…
Many CAR-T programs stall between a promising construct and a product that can be made reliably at scale. #Nucelion one of India’s first dedicated cell and gene therapy CRDMOs, closes that gap.
Sheela Panicker retweeted
#BharatBiotech's subsidiary #Nucelion has partnered with #VeGenBio to manufacture an advanced #cancer therapy.
The collaboration marks Bharat Biotech's expansion into the cell and #genetherapy market.
business-standard.com/s/2gA6… | @sohinidastweets
Sheela Panicker retweeted
Nucelion Therapeutics, a subsidiary of Bharat Biotech, has partnered with VeGen Bio to manufacture VL-2511, a dual-target CAR-T therapy for multiple myeloma, to improve production efficiency and patient access.
thehindubusinessline.com/new…
Sheela Panicker retweeted
India's Viyona Fintech plans to enter Zimbabwe with Tap and Pay, a platform that allows small businesses to accept contactless payments using Android smartphones instead of buying POS terminals.
Meanwhile, Zimbabwe is currently in talks with India’s National Payments Corporation of India to introduce UPI-based national payment infrastructure. The talks are expected to be concluded by 31 October 2026.
Viyona is targeting local banks, payment providers and merchant networks for integration before expanding across Africa.
The rollout still requires regulatory approvals, payment network certification and local partnerships. Merchant fees, launch dates and compatibility with Zimbabwe's existing Zimswitch infrastructure remain unclear.
India's #Viyona #Fintech Advances Expansion with Tap & Pay SoftPOS Launch in #Zimbabwe, Eyes #Africa’s $2 Trillion Payments Market @viyonafintech16
42
Sheela Panicker retweeted
Indian Startup Viyona Fintech Plans Tap & Pay Rollout in Zimbabwe
#Africa #DigitalPayments #Zimbabwe #FintechStartup #UPI #DigitalPayments #TapandPay #Finance #DigitalTransactions
startupstars.in/topstories/i… via @Startupstars_IN
Sheela Panicker retweeted
Hyderabad-based Viyona Fintech is targeting Zimbabwe as its entry point into the African market, with plans to deploy its Tap & Pay technology to expand merchant payment acceptance and tap into the continent’s growing digital payments ecosystem.
The company, an NPCI-certified Technology Service Provider (TSP), is in discussions with the Government of Zimbabwe to facilitate the proposed rollout.
It is also identifying local acquiring banks, payment service providers and merchant networks as potential integration partners. Viyona’s expansion comes as African countries explore digital payment infrastructure, including India’s Unified Payments Interface (UPI).
READ MORE: uniindia.com/business-econom…
